If your foreign cosmetics facility is already registered with FDA under MoCRA, you may one day need to change the U.S. agent named on your registration. Maybe your current agent stopped responding. Maybe you’re consolidating vendors, cutting costs, or moving to a provider with broader service. Whatever the reason, the transfer process is straightforward — but it has to be done correctly, because a facility without a designated U.S. agent is not in compliance.
Here’s how a U.S. agent change works, what information the new agent needs, how long it takes, and how to avoid a dangerous gap in representation.
Why facilities switch U.S. agents
Common reasons include:
- The current agent is unresponsive. FDA communications — inspection notices, information requests, renewal reminders — go to the agent first. If your agent isn’t forwarding them promptly, you’re flying blind.
- Service ended or the agent resigned. Agents can and do resign. When that happens, you need a replacement on record quickly.
- Cost or scope changes. Some agents charge per brand or bundle services you don’t need. Others stop offering the service altogether.
- Consolidation. Facilities with multiple sites sometimes move all registrations under one agent to simplify renewals and correspondence.
- Quality concerns. An agent who filed your original registration with errors, or who can’t answer basic questions about renewal timelines, is a liability.
Whatever the trigger, the mechanics are the same: your facility registration must be amended to name the new agent.
The legal mechanism: an amended facility registration
Under MoCRA, your U.S. agent is designated in your facility registration — the Form FDA 5066 submission filed through FDA Cosmetics Direct. Changing the agent is not a separate “transfer form.” It is done by filing an amended facility registration that updates the U.S. agent contact information to the new agent’s details.
Key points to understand:
- The amendment is filed through Cosmetics Direct, the same portal as the original registration, using your facility’s existing FEI number.
- The amendment updates only what changed — in this case, the U.S. agent’s name, email, and phone number. The rest of your registration (facility details, FEI, product categories) carries over.
- Only one U.S. agent is on record at a time. The amended filing replaces the previous agent’s information. There is no period where two agents are simultaneously designated.
- FDA does not issue a new registration certificate for an amendment — because FDA does not issue registration certificates at all. Proof of the change is the accepted submission record (Submission ID) for the amended filing.
Who files the amendment?
In practice, the incoming agent typically prepares and files the amended registration, since they are the party being newly designated and they sign the submission’s confirmation statement. Before filing, the new agent should have:
- Your written authorization to act as your U.S. agent
- Your facility’s FEI number and current registration details
- Confirmation from you that the information in the amendment is accurate
This is also why reputable agents require your explicit written approval of the exact data being filed before they submit anything. The amendment becomes part of your official FDA record — it should never be filed on autopilot.
What your new agent needs from you
To prepare an accurate amended registration, the incoming agent will need:
- Your facility’s FEI number (FDA Establishment Identifier). This is the anchor for the existing registration. If you don’t know it, the agent can look it up through FDA’s FEI Search Portal — but never file an amendment against the wrong FEI.
- The facility’s legal name and physical address exactly as registered.
- The current registration details, including the existing Submission ID if available, so the amendment references the correct record.
- Responsible person and contact details currently on file, in case anything else needs updating at the same time.
- A signed authorization letter appointing the new agent. This is a business-practice document — FDA’s portal doesn’t require an appointment letter to be uploaded, but a professional agent keeps one on file for every facility they represent.
If your previous agent also handled your product listings (Form FDA 5067), clarify with the new agent whether product listings are included in their service or handled separately. (At US MoCRA Agent, product listings are not part of the launch offering — facility registration and agent representation are.)
Timing: how long a transfer takes
There is no FDA-mandated waiting period for an agent change. The timeline is driven by preparation, not by the agency:
- Information gathering (a few days): You provide the new agent with your FEI, current registration details, and signed authorization.
- Human review and your written approval: The agent assembles the amended data and you approve the exact filing contents. Never skip this step — errors in an amendment create a second round of corrections.
- Filing: The amended registration is submitted through Cosmetics Direct. Like original registrations, the submission goes through validation and, once accepted, generates a Submission ID as proof of filing.
In practice, a clean transfer with complete information can be prepared and filed within about a week. The longest delays come from missing FEI numbers, unresponsive prior agents who won’t share registration details, or corrections needed after a sloppy first filing.
The danger of a gap in representation
The single most important rule of changing agents: never let your facility sit without a designated U.S. agent.
Here’s why the gap matters:
- FDA sends time-sensitive communications to the agent on record. If your old agent has resigned or stopped cooperating and no new agent is designated yet, FDA notices may go to a dead inbox. Missed correspondence can escalate into compliance problems you don’t find out about until it’s serious.
- Biennial renewal reminders go to the agent’s email. If your renewal comes due during a gap, nobody gets the reminder.
- A facility without a U.S. agent is not meeting its MoCRA obligations. The statute requires foreign facilities to have a U.S. agent. Operating in that gap is a compliance exposure, not a paperwork technicality.
How to sequence the change safely
- Appoint the new agent first. Get the authorization signed and the amended registration prepared while the old agent is still on record.
- File the amendment promptly. Once you’ve approved the filing contents, the new agent submits it without delay.
- Then close out the old relationship. Confirm with the prior agent that they consider their representation ended and that they will forward any stray correspondence received during the transition.
This order — new agent designated before the old one exits — keeps continuous coverage. The amendment itself is what formally moves the designation; the old agent doesn’t need to “release” anything in FDA’s system for the new filing to take effect.
What to look for in your next agent
Since you’re switching anyway, use the opportunity to upgrade. A reliable U.S. agent should offer:
- A real, monitored contact point — an email and phone number where FDA communications actually get read and forwarded to you.
- Human review before every filing, with your written approval of the exact data submitted.
- Transparent pricing — a clear one-time onboarding fee and monthly representation fee, per facility, with no surprise per-brand surcharges.
- Renewal handling — biennial facility-registration renewal should be part of the ongoing service, not a surprise invoice every two years.
- A clean exit — if you ever cancel, the agent should file a formal resignation rather than silently abandoning your registration.
Switching to US MoCRA Agent
If you’re considering a change, here’s how it works with us:
- $450 one-time onboarding per facility, plus $34.99/month for continuous representation. No per-brand surcharge.
- We prepare the amended facility registration naming US MoCRA Agent as your U.S. agent, review every field with you, and file only after your written approval.
- Biennial renewal filing is included while you’re subscribed.
- If you ever cancel, the paid month runs out and we file a formal resignation — your registration is never silently abandoned.
US MoCRA Agent is a private service provider and is not affiliated with the FDA. To start a transfer, reach out at usmocra@outlook.com, call +1 909-997-0000, or see pricing.
Frequently asked questions
Do I need my old agent’s permission to switch to a new U.S. agent?
No. The change is made by filing an amended facility registration naming the new agent. The old agent doesn’t approve or release anything in FDA’s system. That said, notify the prior agent in writing that their representation has ended, and ask them to forward any correspondence received during the transition.
Will changing my U.S. agent affect my FEI number or registration?
No. Your FEI number stays the same — it’s tied to your physical facility, not your agent. The amendment updates only the agent information on your existing registration. Your registration history, product listings, and renewal schedule carry over unchanged.
How quickly should I appoint a replacement if my agent resigns?
Immediately. A foreign facility is required to have a U.S. agent designated at all times, and FDA communications go to the agent on record. Start the transfer the moment you learn of a resignation — gather your FEI and registration details, sign authorization with the new agent, and get the amended registration filed without delay.
Will FDA send me a new certificate after the agent change?
No — FDA does not issue registration certificates, for original registrations or amendments. Your proof of the change is the accepted submission record (Submission ID) for the amended facility registration. Anyone promising you an “FDA certificate” for the transfer is misrepresenting how the system works.
This article is for educational purposes only and is not legal advice. US MoCRA Agent is a private service provider and is not affiliated with or endorsed by the FDA. Regulatory details are based on FDA’s published guidance and are current as of September 2026; always verify requirements against FDA’s official sources before acting.